ENTRY       D08837                      Drug
NAME        Aclidinium bromide (JAN/USAN/INN);
            Tudorza pressair (TN);
            Eklira genuair (TN)
PRODUCT     TUDORZA PRESSAIR (AstraZeneca Pharmaceuticals LP)
FORMULA     C26H30NO4S2. Br
EXACT_MASS  563.08
MOL_WEIGHT  564.5547
CLASS       Neuropsychiatric agent
             DG01491  Muscarinic cholinergic receptor antagonist
            Metabolizing enzyme substrate
             DG02973  BCHE substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
              DG01522  CYP3A4 inhibitor
             DG01915  CYP3A5 inhibitor
REMARK      Therapeutic category: 2259
            ATC code: R03BB05
            Product: D08837<JP/US>
            Product (mixture): D11857<US>
EFFICACY    Bronchodilator, Muscarinic acetylcholine receptor antagonist
  DISEASE   Chronic obstructive pulmonary disease [DS:H01714]
COMMENT     Quaternary ammonium compound
TARGET      CHRM [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
  PATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway
            hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction
            hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse
METABOLISM  Enzyme: BCHE [HSA:590]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
                R03BB Anticholinergics
                 R03BB05 Aclidinium bromide
                  D08837  Aclidinium bromide (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Bronchodilators, Anticholinergic
               Aclidinium
                D08837  Aclidinium bromide (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               225  Bronchodilators
                2259  Others
                 D08837  Aclidinium bromide (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01491  Muscarinic cholinergic receptor antagonist
               D08837  Aclidinium bromide
             Metabolizing enzyme substrate
              DG02973  BCHE substrate
               D08837  Aclidinium bromide
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               D08837  Aclidinium bromide
              DG02852  CYP3A/CYP3A4 inhibitor
               DG01522  CYP3A4 inhibitor
                D08837  Aclidinium bromide
              DG01915  CYP3A5 inhibitor
               D08837  Aclidinium bromide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM
                 D08837  Aclidinium bromide (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08837
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D08837
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08837
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08837
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08837
DBLINKS     CAS: 320345-99-1
            PubChem: 96025520
            ChEBI: 65344
            LigandBox: D08837
ATOM        34
            1   C1d C    23.0773  -15.4815
            2   C8y C    23.0773  -14.0754
            3   C7a C    21.8117  -16.1847
            4   O7a O    20.6165  -15.4815
            5   O6a O    21.8117  -17.5908
            6   C1y C    19.4214  -16.1847
            7   C1y C    18.1559  -15.4815
            8   C1x C    19.4214  -17.6611
            9   C1x C    16.8903  -16.1847
            10  C1x C    18.5777  -16.7471
            11  N2y N    18.1559  -18.3642 #+
            12  C1x C    16.8903  -17.5908
            13  C1x C    17.7339  -16.9580
            14  O1a O    24.2725  -14.7785
            15  C1b C    18.1559  -19.7703
            16  C8x C    24.2149  -13.2489
            17  C8x C    23.7804  -11.9116
            18  C8x C    22.3743  -11.9116
            19  S2x S    21.9398  -13.2489
            20  C1b C    16.9381  -20.4734
            21  C1b C    15.7373  -19.7799
            22  O2a O    14.5447  -20.4684
            23  C8y C    13.3483  -19.7774
            24  C8x C    13.3483  -18.3644
            25  C8x C    12.1306  -17.6613
            26  C8x C    10.9129  -18.3644
            27  C8x C    10.9128  -19.7773
            28  C8x C    12.1305  -20.4805
            29  C8y C    24.0532  -16.7238
            30  C8x C    24.5155  -18.0413
            31  C8x C    25.9112  -18.0087
            32  C8x C    26.3117  -16.6712
            33  S2x S    25.1634  -15.8771
            34  X   Br   11.7579  -13.5833 #-
BOND        37
            1     1   2 1
            2     1   3 1
            3     3   4 1
            4     3   5 2
            5     6   4 1 #Up
            6     6   7 1
            7     6   8 1
            8     7   9 1
            9     7  10 1
            10    8  11 1
            11    9  12 1
            12   10  13 1
            13   11  12 1
            14   11  13 1
            15    1  14 1
            16   11  15 1
            17    2  16 2
            18   16  17 1
            19   17  18 2
            20   18  19 1
            21    2  19 1
            22   15  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   23  24 2
            27   24  25 1
            28   25  26 2
            29   26  27 1
            30   27  28 2
            31   23  28 1
            32   29  30 2
            33   30  31 1
            34   31  32 2
            35   32  33 1
            36   29  33 1
            37    1  29 1
///
